Search

everythinglearnresearchcommunity

for

Search:↓

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Three new gene mutations cause rickets and hair loss, treatable with high calcium and calcidol, but hair regrowth is rare.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

JAK inhibitors are effective treatments for alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Activating TLR3 boosts autophagy gene expression in skin cells.

Mitochondriopathy may cause eyelash loss.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Two red-haired men with alopecia areata regrew black hair instead of red.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Alopecia areata can show unusual red-dotted vessels and dithranol treatment may mask typical patterns.

Two siblings have a rare hair condition caused by a new genetic variant.

A woman with myotonic dystrophy had multiple skin tumors on her scalp, suggesting a genetic link.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Retinoic acid affects skin and hair health by working with specific receptors, and its absence can lead to hair loss and skin changes.

Genetic discoveries are leading to new treatments for alopecia areata.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Early recognition and treatment of VATS in transplant patients improve outcomes.